RxDoctor Payments Data

Lindsey Monti, PA

Physician Assistant · Smithfield, RINPI 1689044919

Payments from drug & device makers

$403in general payments, 2019–2025

Across 18 payments — averaging $22.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$128
  • Pfizer$125
  • GSK$38
  • Johnson & Johnson$38
  • Almatica Pharma LLC$31
  • AbbVie$24
  • plus $19 from 1 others

What the payments were for

  • Food & beverage$403100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$403 in reported general payments places this provider in the 65th percentile of 481 physician assistant providers in Rhode Island.

See all physician assistant providers in Rhode Island

Medicare billing

Part B allowed, 2024
$45,359
Medicare patients
86
Services billed
521

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl44$66,610
Aripiprazole52$8,119
TrintellixVortioxetine Hydrobromide11$5,263
Lamotrigine271$3,688
Quetiapine Fumarate107$2,967
Buspirone Hcl191$2,807
Mirtazapine131$2,349
Trazodone Hcl186$2,071
Oxcarbazepine45$1,826
Risperidone77$1,715
Prazosin Hcl62$1,627
Divalproex Sodium ErDivalproex Sodium28$1,469
Hydroxyzine Hcl67$1,351
Bupropion XlBupropion Hcl48$1,322
Venlafaxine Hcl ErVenlafaxine Hcl67$1,260

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$24$66,61044 claims
Almatica Pharma LLCSertraline Hcl$31$1,049109 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 481 physician assistant providers in Rhode Island.

Other physician assistant in Smithfield

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →